TMOEarnings Release财报快讯SEC sourceSEC 来源Source link原始来源August 5, 20262026/8/5by InvestLog AIInvestLog AI 整理

Thermo Fisher Scientific Inc. (TMO) 2026 Q2 period ended 2026-06-27 financial resultsThermo Fisher Scientific Inc. (TMO) 2026 Q2 period ended 2026-06-27 财报发布

Key Results

Thermo Fisher Scientific Inc. reported revenue $12.0B, operating profit $2.1B, net income $1.7B, operating margin 17.4%.

Profitability and Cash Flow

Period: 2026 Q2 period ended 2026-06-27

Revenue: $12.0B; YoY: +10.5%; QoQ: +9.0%

Gross profit: $4.9B; Gross margin: 41.2%

Operating income: $2.1B; Operating margin: 17.4%; YoY: +8.9%; QoQ: +12.0%

Net income: $1.7B; GAAP diluted EPS: $4.68; YoY: +7.4%; QoQ: +5.1%

Operating cash flow: $2.1B; Capex: $450M; Free cash flow: $1.7B

Cash: $4.1B; Total debt: $42.5B; Net debt: $38.5B

Official release: 10-Q

核心结果

Thermo Fisher Scientific Inc. 公布2026 Q2 period ended 2026-06-27财报：营收 $12.0B，营业利润 $2.1B，净利润 $1.7B，营业利润率 17.4%。

财务指标

期间：2026 Q2 period ended 2026-06-27

营收：$12.0B；同比：+10.5%；环比：+9.0%

毛利润：$4.9B；毛利率：41.2%

经营利润：$2.1B；经营利润率：17.4%；同比：+8.9%；环比：+12.0%

净利润：$1.7B；GAAP 稀释 EPS：$4.68；同比：+7.4%；环比：+5.1%

经营现金流：$2.1B；资本开支：$450M；自由现金流：$1.7B

现金：$4.1B；总债务：$42.5B；净债务：$38.5B

View TMO stock details ->查看 TMO 个股详情 ->

This earnings research was prepared from company results, regulatory filings, and financial statements. It is for informational purposes only and does not constitute investment advice.这篇财报研究基于公司业绩公告、监管文件和财务报表整理。内容仅供参考，不构成投资建议。